Zevra Therapeutics, Inc. (ZVRA)
8.81
-0.01
(-0.11%)
USD |
NASDAQ |
Dec 30, 16:00
8.79
-0.02
(-0.23%)
Pre-Market: 08:02
Zevra Therapeutics Market Cap: 495.98M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 324.19M |
| Akebia Therapeutics, Inc. | 421.93M |
| NovaBay Pharmaceuticals, Inc. | 781.27M |
| Palatin Technologies, Inc. | 13.47M |
| Theriva Biologics, Inc. | 6.613M |
Market Cap Related Metrics
| PE Ratio | 13.97 |
| PS Ratio | 5.703 |
| Price to Book Value | 3.725 |
| Price | 8.81 |
| Earnings Yield | 7.16% |
| Normalized PE Ratio | 6.161 |